4Lim SG,Jia JD, Hwang SG. Baseline characteristics and early response predictors of therapeutic outcomes in tel- bivudine or lamivudine - treated HBeAg - positive chronic hepatitis B patients [ J ]. Hepatol Int, 2008,2 : S76. OL-105.
5Keeffe EB,Zeuzem S,Koff RS,et al. Report of an inter- national workshop : Roadmap for management of patients receiving oral therapy for chronic hepatitis B [ J ]. Clin Gastroenterol Hepato1,2007,5 ( 8 ) :890-897.
6Yuen MF, Wong DKH, Fung J, et al. Predictive value of HBVDNA Levels at frequent time points during early and maintenance phase of 5 -year Lamivudine and mu- tational profiles of reverse transcriptase (RT) and sur- face(S) genes[ J]. Hepatology,2006 ,44 :557A.
